References
- Congdon N, O’Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477–485.
- Bloom HG, Ahmed I, Alessi CA, et al. Evidence-based recommendations for the assessment and management of sleep disorders in older persons. J Am Geriatr Soc 2009;57:761–789.
- Brugger P, Marktl W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995;345:1408.
- Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer’s disease. Exp Gerontol 2003;38:199–206.
- Rosen R, Hu DN, Perez V, et al. Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients. Mol Vis 2009;15:1673–1679.
- Taylor DJ, Mallory LJ, Lichstein KL, et al. Comorbidity of chronic insomnia with medical problems. Sleep 2007;30:213–218.
- Szklo-Coxe M, Young T, Peppard PE, et al. Prospective associations of insomnia markers and symptoms with depression. Am J Epidemiol 2010;171:709–720.
- Morin CM, LeBlanc M, Daley M, et al. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123–130.
- Klein R, Meuer SM, Myers CE, et al. Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium. Ophthalmic Epidemiol 2014;21:14–23.
- U.S. Department of Health and Human Services [USDHHS]. 2008 Physical Activity Guidelines for Americans. Washington (DC), USA, USDHHS, 2008. Accessed December 3, 2014 from: www.health.gov/paguidelines
- Buysse DJ, Reynolds CF, III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
- Girschik J, Heyworth J, Fritschi L. Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidermal 2013;177:316–327.
- Lichstein K, Durrence H, Riedel B, et al. Epidemiology of sleep: age, gender and ethnicity. 1st ed. Mahwah, NJ: Psychology Press, 2004.
- Patel SR, Ayas NT, Malhotra MR, et al. A prospective study of sleep duration and mortality risk in women. Sleep 2004;27:440–444.
- Tamakoshi A, Ohno Y. Self-reported sleep duration as a predictor of all cause mortality: results from the JACC study, Japan. Sleep 2004;27:51–54.
- Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829–1836.
- Velez-Montoya R, Oliver SC, Olson JL, et al. Current knowledge and trends in age-related macular degeneration: genetics, epidemiology, and prevention. Retina 2014;34:423–441.
- Ohkuma T, Fujii H, Iwase M, et al. Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry. PLoS One 2013;8(11):e78968.
- Marshall NS, Glozier N, Grunstein RR. Is sleep duration related to obesity? A critical review of the epidemiological evidence. Sleep Med Rev 2008;12:289–298.
- Youngstedt SD, Kripke DF. Long sleep and mortality: rationale for sleep restriction. Sleep Med Rev 2004;8:159–174.
- Nesmith BL, Ihnen M, Schaal S. Poor responders to bevacizumab pharmacotherapy in age-related macular degeneration and in diabetic macular edema demonstrate increased risk for obstructive sleep apnea. Retina 2014;34:2423–2430.
- Campos CI, Nogueira CH, Fernandes L. Aging, circadian rhythms and depressive disorders: a review. Am J Neurodegener Dis 2013;2:228–246.
- Marchiafava PL, Longoni B. Melatonin as an antioxidant in retinal photoreceptors. J Pineal Res 1999;26:184–189.
- Liang FQ, Green L, Wang C, et al. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res 2004;78:1069–1075.
- Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 2004;15:181–183.
- Popescu ML, Boisjoly H, Schmaltz H, et al. Explaining the relationship between three eye diseases and depressive symptoms in older adults. Invest Ophthalmol Vis Sci 2012;53:2308–2313.
- Perlis ML, Smith LJ, Lyness JM, et al. Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med 2006;4:104–113.
- Szklo-Coxe M, Young T, Peppard PE, et al. Prospective associations of insomnia markers and symptoms with depression. Am J Epidemiol 2010;171:709–720.
- Born J, Lange T, Hansen K, et al. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol 1997;158:4454–4464.
- Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007;30:1145–1152.
- Kinnucan JA, Rubin DT, Ali T. Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol Hepatol (NY) 2013;9:718–727.
- Killingsworth MC, Sarks JP, Sarks SH. Macrophages related to Bruch’s membrane in age-related macular degeneration. Eye (Lond) 1990;4(Pt 4):613–621.
- Miao H, Tao Y, Li XX. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis 2012;18:574–580.
- Lauderdale DS, Knutson KL, Yan LL, et al. Self-reported and measured sleep duration: how similar are they? Epidemiology 2008;19:838–845.
- Ikehara S, Iso H, Date C, et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 2009;32:295–301.
- Verkasalo PK, Lillberg K, Stevens RG, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res 2005;65:9595–9600.
- Leger D, Beck F, Richard JB, et al. The risks of sleeping “too much”. Survey of a national representative sample of 24671 adults (INPES Health Barometer). PLoS One 2014;9:e106950.